InterVenn

InterVenn Biosciences is a digital-biology company applying artificial intelligence and mass spectrometry to glycoproteomics, the large-scale study of glycosylated proteins, to discover novel biomarkers for precision medicine. Its proprietary platform integrates liquid chromatography and tandem mass spectrometry (LC-MS) with AI-driven analysis (including the OpenPIP software) to identify and quantify glycopeptides and glycan structures across complex diseases such as cancer. Surfaced as a portfolio company of amplify-partners and softbank-vision-fund and added to the API Evangelist network. InterVenn publishes no public developer API, portal, or specifications as of this enrichment pass; this profile carries company identity and domain-security posture only.

InterVenn is profiled on the APIs.io network. Tagged areas include Company, Digital Biology, Glycoproteomics, Proteomics, and Mass Spectrometry.

InterVenn’s developer surface includes support, engineering blog, and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

CompanyDigital BiologyGlycoproteomicsProteomicsMass SpectrometryPrecision MedicineBiomarkersArtificial IntelligenceLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 3.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/intervenn: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: intervenn
name: InterVenn
description: InterVenn Biosciences is a digital-biology company applying artificial intelligence and mass spectrometry to
  glycoproteomics, the large-scale study of glycosylated proteins, to discover novel biomarkers for precision medicine. Its
  proprietary platform integrates liquid chromatography and tandem mass spectrometry (LC-MS) with AI-driven analysis (including
  the OpenPIP software) to identify and quantify glycopeptides and glycan structures across complex diseases such as cancer.
  Surfaced as a portfolio company of amplify-partners and softbank-vision-fund and added to the API Evangelist network. InterVenn
  publishes no public developer API, portal, or specifications as of this enrichment pass; this profile carries company identity
  and domain-security posture only.
url: https://raw.githubusercontent.com/api-evangelist/intervenn/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- amplify-partners
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
image: https://intervenn.com/images/intervenn-favicon1.jpg
tags:
- Company
- Digital Biology
- Glycoproteomics
- Proteomics
- Mass Spectrometry
- Precision Medicine
- Biomarkers
- Artificial Intelligence
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://intervenn.com
- type: PrivacyPolicy
  url: https://intervenn.com/privacy-policy/
- type: Support
  url: https://intervenn.com/contact/
- type: Blog
  url: https://intervenn.com/news-and-events/
- type: DomainSecurity
  url: security/intervenn-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence